We've hit a major milestone by setting up our first Vision One system at Klinik Sankt Elisabeth in Heidelberg, Germany
THERMOMIND are celebrating International Women’s Day and embracing equity by driving their mission to save lives in early breast cancer detection
We were excited to launch our international EU consortium study
THERMOBREAST, an innovative and non-contact breast cancer detection and patient monitoring system, is set to revolutionize the way breast cancer is detected.
This #WomensHealthMonth, let us highlight the silent risk of dense breast tissue, a factor affecting 1 in 2 women over 40.
THERMOMIND are proud to be announced as the winner of the 2023 Next-Gen Women Entrepreneurship Award.
THERMOMIND, were privileged to hear from Shiran Gross, a young breast cancer survivor, who spoke at the THERMOBREAST EU consortium launch meeting in Haifa.
The European Union has announced that the THERMOBREAST proposal has been successfully evaluated
Read about our AI-enabled, contact-free, radiation-free thermal screening modality for detecting early-stage breast tumors which is at clinical trial stage in the latest article in ISRAEL21c.
THERMOMIND are proud to be featured in the Jerusalem Post
THERMOMIND Ltd., the leader of the THERMOBREAST EU-funded project, hosted a kick-off meeting on the 6th and 7th of February 2023 in Haifa, Israel